Citations

Showing 10 of 108104 citations.

Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data
Anderson, Joseph C. , Robinson, Christina M. , Hisey, William , Butterly, Lynn F. , Limburg, Paul J.

Mayo Clinic

Cancer Prevention Research | April 4, 2022 | Volume: 15 | Issue: 7 | Pages: 455-464

10.1158/1940-6207.capr-21-0581 | PMID 35378546 Get It

Abstract Few studies compare fecal immunochemical test (FIT) and multi-target stool DNA (mt-sDNA) outcomes in practice. We compared colonoscopy yield following FIT+ or mt-sDNA+ tests to colonoscopies without preceding stool tests in the comprehensive population-based New Hampshire Colonoscopy Registry (NHCR). Outcomes were any neoplasia and an ordered outcome: adenocarcinoma, advanced neoplasia (adenoma/serrated polyp ≥ 1 cm/villous/high-grade dysplasia), nonadvanced neoplasia, or normal. Our total sample included 306 mt-sDNA+ (average age ± SD 67.0 ± 7.9), 276 FIT+ (66.6 ± 8.7), and 50,990 colonoscopy-only patients (61.8 ± 8.1). Among average-risk patients (N = 240 mt-sDNA+, N = 194 FIT+, N = 26,221 colonoscopy only), mt-sDNA+ patients had a higher risk for any neoplasia (67.1%) compared with FIT+ (54.6%, P = 0.00098) or colonoscopy (40.8%, P < 0.0001). Severity of findings and histology subtypes differed across the three groups (P < 0.0001 for both), with a higher yield of advanced findings in mt-sDNA+ patients. In particular, clinically relevant serrated polyps (hyperplastic polyps ≥10 mm/traditional serrated adenomas/sessile serrated polyps) were detected at a higher frequency in mt-sDNA+ patients as compared with FIT+ or colonoscopy-only patients. Even after adjustment, patients with positive mt-sDNA [OR = 2.82; 95% confidence interval (CI), 2.00–4.02] or FIT+ tests (OR = 1.67; 95% CI, 1.19–2.36) were more likely to have histologically more advanced findings than colonoscopy alone. At follow-up colonoscopy, mt-sDNA+ tests were more likely to predict neoplasia than FIT+, largely due to increased detection of serrated polyps. Prevention Relevance: Colorectal cancer screening options include colonoscopy and stool-based tests, including the fecal immunochemical test (FIT) and the multi-target stool DNA (mt-sDNA) test which, if positive, must be followed by a colonoscopy. Assessing “real-world” outcomes of colonoscopies following positive stool tests can inform their clinical use. See related Spotlight, p. 417
Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice
Friedman, David J. , Kizerwetter, Monika , Belmonte, Paul , Rajcula, Matthew, Theodore, Keith, Lee, Hyun Se Kim , Shapiro, Michael J. , Dong, Haidong , Shapiro, Virginia Smith , Kim Lee, Hyun Se , Shapiro, Virginia S , Belmonte, Paul J , Dong, Haidong , Friedman, David , Kizerwetter, Monika , Shapiro, Michael Jeremy

Mayo Clinic

The Journal of Immunology | April 4, 2022 | Volume: 208 | Issue: 8 | Pages: 1845-1850

10.4049/jimmunol.2101165 | PMID 35379746 Get It

Abstract Inhibitory receptors have a critical role in the regulation of immunity. Siglecs are a family of primarily inhibitory receptors expressed by immune cells that recognize specific sialic acid modifications on cell surface glycans. Many tumors have increased sialic acid incorporation. Overexpression of the sialyltransferase ST8Sia6 on tumors led to altered immune responses and increased tumor growth. In this study, we examined the role of ST8Sia6 on immune cells in regulating antitumor immunity. ST8Sia6 knockout mice had an enhanced immune response to tumors. The loss of ST8Sia6 promoted an enhanced intratumoral activation of macrophages and dendritic cells, including upregulation of CD40. Intratumoral regulatory T cells exhibited a more inflammatory phenotype in ST8Sia6 knockout mice. Using adoptive transfer studies, the change in regulatory T cell phenotype was not cell intrinsic and depended on the loss of ST8Sia6 expression in APCs. Thus, ST8Sia6 generates ligands for Siglecs that dampen antitumor immunity.
Implementation of Clinical Practice Guidelines for Hospitalized Patients With COVID-19 in Academic Medical Centers
Berger, Amy, Simchoni, Noa , Auerbach, Andrew D., Brode, W. Michael , Kuperman, Ethan , Kubey, Alan , Group, HOMERuN COVID-19 Collaborative, Auerbach, Andrew D. , Raffel, Katie E. , Kubey, Alan A , Group, HOMERuN COVID-19 Collaborative

Mayo Clinic

JAMA Network Open | April 4, 2022 | Volume: 5 | Issue: 4 | Pages: e225657

10.1001/jamanetworkopen.2022.5657 | PMID 35377428 Get It

Pediatric Celiac disease and Selective IgA Deficiency: Unexpected Sequence of Events
Andersen, Maria Christine Ernst, Madsen, Gunvor, Lillevang, Søren Thue , Husby, Steffen , Sander, Stine Dydensborg , Murray, Joseph A.

Mayo Clinic

No container title available | April 4, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1482929/v1 Get It

Abstract Purpose Selective IgA deficiency (IgAD) is the most common primary immunodeficiency and may be associated with autoimmune diseases such as celiac disease (CeD). Although IgAD is thought to precede CeD and autoimmunity, the association between the two conditions has not been clarified. Methods Routine techniques were used to measure serum IgA and TG2-IgA and for immunohistochemistry. Results We report two childhood cases of IgA deficiency that evolved after the diagnosis of CeD and the start of a gluten-free diet. Histology showed persistence of IgA in the intestinal mucosa. Conclusion Both children with CeD showed IgA deficiency that developed after the initiation of a gluten-free diet. This supports IgA deficiency as being an autoimmune process that develops gradually and occurs due to specific defects in immunoregulation.
Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis
Cascino, Gregory D. , Wheless, James W. , Sperling, Michael R. , Desai, Jay , Vázquez, Blanca , Samara, Emil, Misra, Sunita N. , Carrazana, Enrique , Group, for the DIAZ.001.05 Study, Wheless, James W , Hogan, R Edward , Sperling, Michael R , Misra, Sunita N , Carrazana, Enrique , Rabinowicz, Adrian L , Cascino, Gregory D , Tarquinio, Daniel Charles , Rabinowicz, Adrián L. , Group, for the DIAZ.001.05 Study

Mayo Clinic

Epilepsia | April 4, 2022 | Volume: 63 | Issue: 7 | Pages: 1714-1723

10.1111/epi.17249 | PMID 35377464 Get It

AbstractObjectiveCurrent diazepam nasal spray labeling requires waiting 4 h before administering a second dose. The objective of the current analyses was to examine safety and pharmacokinetic profiles of second doses of diazepam nasal spray given 0−4 h after the first dose.MethodsTwo datasets were analyzed. The first, a long‐term, repeat‐dose safety study of diazepam nasal spray, compared rates of treatment‐emergent adverse events (TEAEs), serious TEAEs, and treatment‐related TEAEs for patients receiving ≥1 second dose ≤4 h versus all second doses >4 h after the first. The second was a population pharmacokinetic analysis using data from three phase 1 studies to model drug exposure when a second dose of diazepam nasal spray was administered across multiple time points (1 min−4 h) following the first dose.ResultsIn the repeat‐dose safety study, a second dose of diazepam nasal spray was administered ≤24 h after the first to treat 485 seizure clusters in 79 patients. Rates of TEAEs were similar between patients receiving ≥1 second dose in ≤4 h (89.5%, n = 38) compared with >4–24 h only (80.5%, n = 41). The most common treatment‐related TEAEs were associated with nasal discomfort, which was mild or moderate and transient. There were no reports of respiratory or cardiac depression. The pharmacokinetic simulations of second doses predicted comparable elevations of plasma diazepam concentrations with administrations across a range of intervals after the first dose (1 min−4 h).SignificanceThese data indicate that the safety and pharmacokinetic profiles of a second dose of diazepam nasal spray administered within 4 h of the first dose are consistent with those associated with current labeling. This is potentially important for patients with seizure clusters who have a recurrent seizure within 4 h of first treatment and might benefit from immediate retreatment to reduce the risk of progression to status epilepticus.
Cardiopulmonary Outcomes After the Nuss Procedure in Pectus Excavatum
Jaroszewski, Dawn E. , Farina, Juan M. , Gotway, Michael B., Stearns, Joshua D., Peterson, Michelle A., Pulivarthi, Venkata S. K. K., Bostoros, Peter, Abdelrazek, Ahmad S., Gotimukul, Ashwini, Majdalany, David S., Wheatley, Courtney M. , Wheatley-Guy, Courtney M , Arsanjani, Reza , Farina, Juan M , Jaroszewski, Dawn E. , Gotway, Michael B., Stearns, Joshua D., Peterson, Michelle A., Pulivarthi, Venkata S. K. K., Bostoros, Peter, Abdelrazek, Ahmad , Gotimukul, Ashwini, Majdalany, David S.

Mayo Clinic

Journal of the American Heart Association | April 4, 2022 | Volume: 11 | Issue: 7 | Pages: No page available

10.1161/jaha.121.022149 | PMID 35377159 Get It

Background Pectus excavatum is the most common chest wall deformity. There is still controversy about cardiopulmonary limitations of this disease and benefits of surgical repair. This study evaluates the impact of pectus excavatum on the cardiopulmonary function of adult patients before and after a modified minimally invasive repair. Methods and Results In this retrospective cohort study, an electronic database was used to identify consecutive adult (aged ≥18 years) patients who underwent cardiopulmonary exercise testing before and after primary pectus excavatum repair at Mayo Clinic Arizona from 2011 to 2020. In total, 392 patients underwent preoperative cardiopulmonary exercise testing; abnormal oxygen consumption results were present in 68% of patients. Among them, 130 patients (68% men, mean age, 32.4±10.0 years) had post‐repair evaluations. Post‐repair tests were performed immediately before bar removal with a mean time between repair and post‐repair testing of 3.4±0.7 years (range, 2.5–7.0). A significant improvement in cardiopulmonary outcomes ( P <0.001 for all the comparisons) was seen in the post‐repair evaluations, including an increase in maximum, and predicted rate of oxygen consumption, oxygen pulse, oxygen consumption at anaerobic threshold, and maximal ventilation. In a subanalysis of 39 patients who also underwent intraoperative transesophageal echocardiography at repair and at bar removal, a significant increase in right ventricle stroke volume was found ( P <0.001). Conclusions Consistent improvements in cardiopulmonary function were seen for pectus excavatum adult patients undergoing surgery. These results strongly support the existence of adverse cardiopulmonary consequences from this disease as well as the benefits of surgical repair.
Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation
Mangaonkar, Abhishek A. , Patnaik, Mrinal M.

Mayo Clinic

Leukemia & Lymphoma | April 4, 2022 | Volume: 63 | Issue: 8 | Pages: 1792-1800

10.1080/10428194.2022.2056175 | PMID 35377828 Get It

Reply to: Atypical presentations of immune‐mediated necrotizing myopathy: Clues and caveats
Nicolau, Stefan , Milone, Margherita , Liewluck, Teerin , Liewluck, T , Nicolau, Stefan

Mayo Clinic

Muscle & Nerve | April 4, 2022 | Volume: 65 | Issue: 6 | Pages: No page available

10.1002/mus.27549 | PMID 35373841 Get It

Diabetic ketoacidosis, cerebral venous sinus thrombosis and fulminant cerebral oedema in COVID-19 infection complicated by Klebsiella pneumoniae infection
Wallace, Lindsey , Hocker, Sara E. , Wallace, Lindsey , DuBrock, Hilary, Bauer, Philippe, DuBrock, Hilary M. , Bauer, Philippe R.

Mayo Clinic

BMJ Case Reports | April 4, 2022 | Volume: 15 | Issue: 4 | Pages: e248046

10.1136/bcr-2021-248046 | PMID 35379681 Get It

We present an unusual case of a woman in her 30s who was admitted for diabetic ketoacidosis (DKA) in the setting of newly diagnosed but late COVID-19 infection with associated Klebsiella pneumoniae infection. Her altered mental status, out of proportion with her metabolic decompensation, revealed a superimposed cerebral venous sinus thrombosis (CVST) with fulminant cerebral oedema and ultimately brain death. This unusual and fulminant case of cerebral oedema in the setting of COVID-19 infection with bacterial infection, DKA and CVST was the perfect storm with multiple interwoven factors. It offered diagnostic and treatment challenges with an unfortunate outcome. This unique case is a reminder that it is important to consider a broad neurological differential in patients with COVID-19 with unexplained neurological manifestations, which may require specific neurointensive care management.